Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Recordati Industria Chimica e Farmaceutica S.p.A. (REC.VI)

Vienna - Vienna Delayed Price. Currency in EUR
38.78+0.02 (+0.05%)
At close: 05:32PM CET
Advertisement

Recordati Industria Chimica e Farmaceutica S.p.A.

1, Via Matteo Civitali
Milan, MI 20148
Italy
39 02 487871
https://www.recordati.com

Sector(s)Healthcare
IndustryDrug Manufacturers—General
Full Time Employees4,300

Key Executives

NameTitlePayExercisedYear Born
Dr. Robert Koremans M.D.CEO & Director135kN/A1962
Ms. Cathrin PettyExec. DirectorN/AN/A1973
Mr. Giampiero MazzaExec. DirectorN/AN/A1969
Mr. Giorgio De PalmaExec. DirectorN/AN/A1974
Mr. Luigi Felice La CorteGroup CFO & Exec. DirectorN/AN/A1969
Ms. Federica De MediciDirector of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Daria GhidoniGroup Gen. CounselN/AN/AN/A
Mr. Giovanni MinoraGroup Audit & ComplianceN/AN/AN/A
Mr. Gabriele FinziExec. VP of Corp. Devel. & LicensingN/AN/AN/A
Mr. Giuseppe GualazziniSr. VP of Group HRN/AN/A1959
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Corporate Governance

Recordati Industria Chimica e Farmaceutica S.p.A.’s ISS Governance QualityScore as of February 1, 2023 is 2. The pillar scores are Audit: 7; Board: 2; Shareholder Rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement